CMS advised Werfen on the deal, while Hogan Lovells advised Omixon. Werfen acquired Omixon Biocomputing. Werfen is a Barcelona-based healthcare company. Omixon Biocomputing is a transplant...
Werfen’s Acquisition of Omixon Biocomputing
Werfen’s €500 Million Five-year Senior Notes Issue
Freshfields has advised Werfen and Linklaters has advised the banks which acted as joint book-running managers for the transaction. Werfen, a worldwide leader in Specialized Diagnostics in...